Video

Hayes Dansky from Janssen Pharmaceuticals: Xarelto Continues to Show Positive Results in Practice

Author(s):

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

Hayes Dansky, MD, of Janssen Pharmaceuticals discussed how real world data can help expand the usage of the anticoagulant and what that can mean for overall patient care during the American College of Cardiology's 65th Annual Scientific Sessions and Expo in Chicago.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.